JP Morgan Chase
MRNS

JP Morgan Chase’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

JP Morgan Chase’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-46,900
Closed -$510K – 8020
2023
Q4 		$510K Buy
46,900
+41,300
+738% +$310K ﹤0.01% 4783
2023
Q3 		$45.1K Hold
5,600
– – ﹤0.01% 5840
2023
Q2 		$60.8K Buy
5,600
+5,200
+1,300% +$44.5K ﹤0.01% 5666
2023
Q1 		$3K Buy
+400
New +$2.51K ﹤0.01% 6372

JP Morgan Chase's MRNS Position: Q1 2025 in Review

JP Morgan Chase sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 487,584 shares — an estimated $261K sold.

JP Morgan Chase first reported a position in MRNS in Q1 2016 and held it in 29 quarters. The position peaked at $3.55M in Q3 2021. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

  • JP Morgan Chase reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 487,584 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $261K.
  • JP Morgan Chase first reported a position in Marinus Pharmaceuticals, Inc in Q1 2016 and held it in 29 quarters.
  • JP Morgan Chase's Marinus Pharmaceuticals, Inc position peaked at $3.55M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.